Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell populationCarmela Ciccarelli(University of L'Aquila), Bianca M. Zani(University of L'Aquila)Molecular CancerFebruary 20, 201610.1186/s12943-016-0501-yCited by 83SaveCiteExport RISWatch citationsRelated PapersAnti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma|Oncology Reports|2022|9